Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 4, 2021
Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancerAlejandra Romero Román, Jose Luis Campo-Cañaveral de la Cruz, Iván Macía, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular LymphomaPier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2009
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patientsVicente Alberola Candel, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2025
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without AmivantamabZofia Piotrowska, Antonio Passaro, Danny Nguyen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2026
Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibodyBen Tran, Mark Voskoboynik, Sang-We Kim, et al.The New England Journal of Medicine|May 15, 2024
Perioperative Nivolumab in Resectable Lung CancerTina Cascone, Mark M Awad, Jonathan D Spicer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2026
Decoding B Cell Signatures of Complete Pathological Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung CancerBelén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre, et al.Cancers|February 13, 2025
Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL TrialSara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino, et al.JTO Clinical and Research Reports|June 8, 2026
Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus StatementAylen Vanessa Ospina-Serrano, Constanza Maximiano-Alonso, Pau Guillén-Sentís, et al.Frontiers in Immunology|March 12, 2024
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphomaLourdes Hontecillas-Prieto, Daniel J García-Domínguez, Natalia Palazón-Carrión, et al.Pageof 5